| ABTS | 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) |
| AMPK | AMP-activated protein kinase |
| CITES | Convention of International Trade in Endangered Species of Wild Fauna and Flora |
| db/db mice | Diabetic and obese mice |
| DPP-4 | Dipeptidyl Peptidase-4 |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| EC50 | Half maximal effective concentration |
| EDTA | Ethylenediaminetetraacetic acid |
| FBG | Fasting Blood Glucose |
| FRAP | Ferric Reducing Antioxidant Power |
| GLP-1 | Glucagon-Like Peptide-1 |
| HbA1c | Glycosylated Haemoglobin |
| IC50 | Half maximal inhibitory concentration |
| ICR mice | Imprinting Control Region mice |
| IDF | International Diabetes Federation |
| IR | Insulin Resistance |
| MeSH | Medical Subject Heading |
| PICO | Population, Intervention, Comparison, Outcome |
| PPAR | Peroxisome Proliferator-Activated Receptor |
| PRISMA | Preferred Reporting Items for Systematic reviews and Meta-Analyses |
| RCT | Randomised clinical trials |
| SGLT2 | Sodium-Glucose Cotransporter-2 |
| SPF/VAF CrljOri ICR mice | Specific Pathogen-Free/Virus Antibody Free Crj: CD-1 ICR mice |